Soligenix
SNGX
#10223
Rank
A$24.58 M
Marketcap
A$2.44
Share price
-1.23%
Change (1 day)
-50.88%
Change (1 year)

Soligenix (SNGX) - Total debt

Total debt on the balance sheet as of September 2025 : A$0.58 Million

According to Soligenix's latest financial reports the company's total debt is A$0.58 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Soligenix - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$2.38 M-53.46%
2023-12-31A$5.12 M-65.91%
2022-12-31A$15.04 M9.51%
2021-12-31A$13.74 M0.57%
2020-12-31A$13.66 M7419.23%
2019-12-31A$0.18 M
2018-12-31N/A
2016-12-31N/A-100%
2015-12-31A$0.4 M-91.32%
2014-12-31A$4.63 M-50.12%
2013-12-31A$9.28 M
2004-12-31A$0.14 M-68.98%
2003-12-31A$0.48 M-62.72%
2002-12-31A$1.29 M204.93%
2001-12-31A$0.42 M-26.44%
2000-12-31A$0.57 M-3.23%
1999-12-31A$0.59 M-8.63%
1998-12-31A$0.65 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$1.00 B 172,109.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$38.64 B 6,630,476.49%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
A$92.10 B 15,802,358.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$69.31 B 11,893,037.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
A$28.11 M 4,724.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$25.84 B 4,433,823.55%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel